SG Americas Securities’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
KGAMU
WPM
MFS
RC
LG
SG Americas Securities's CDLX Position: Q2 2025 in Review
SG Americas Securities sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 1,552 shares — an estimated $28K sold.
SG Americas Securities first reported a position in CDLX in Q3 2018 and held it in 21 quarters. The position peaked at $1.54M in Q2 2022. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.
- SG Americas Securities reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
- SG Americas Securities sold 1,552 Cardlytics shares in Q2 2025, an estimated $28K.
- SG Americas Securities first reported a position in Cardlytics in Q3 2018 and held it in 21 quarters.
- SG Americas Securities's Cardlytics position peaked at $1.54M in Q2 2022.
- 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.
Based on SG Americas Securities's 13F filing for Q2 2025, filed 8 Aug 2025.